What one share of Briacell Therapeutics holds
Briacell Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-04-30; the balance sheet is as of 2026-04-30.
| Profit | −$9.69 |
|---|---|
| Cash and investments | $0.95 |
| Book value | $3.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | — | −$259.83 | — | — | — | $99.84 |
| 2023 | — | −$194.97 | — | — | — | −$35.45 |
| 2024 | — | −$43.68 | $4.16 | −$224.09 | — | −$22.02 |
| 2025 | — | −$62.19 | — | — | — | $9.20 |
Common questions about Briacell Therapeutics
How much does one share of Briacell Therapeutics earn?
Over the last 12 months, Briacell Therapeutics lost $9.69 for each share.
Does Briacell Therapeutics pay a dividend?
Briacell Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Briacell Therapeutics’s book value per share?
Briacell Therapeutics’s book value is $3.23 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of April 30, 2026.
How much cash and debt does each share of Briacell Therapeutics have?
Each share of Briacell Therapeutics has $0.95 of cash and investments, as of April 30, 2026.
Has Briacell Therapeutics bought back shares?
Briacell Therapeutics’s share count rose about 310% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.